Search clinical trials for: RF-CWC
Total 1782 results
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnPlasma Cell Myeloma | Plasma Cell Leukemia in RemissionUnited States
-
The University of Texas Health Science Center,...Eunice Kennedy Shriver National Institute of Child Health and Human Development...Recruiting
-
University of ChicagoNational Cancer Institute (NCI); Multiple Myeloma Research FoundationCompletedMultiple MyelomaUnited States, Canada
-
AmgenCompletedDermatitis, Atopic DermatitisCanada, United States, Japan
-
Vaishali SanchorawalaCelgene CorporationCompletedMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationTerminated
-
M.D. Anderson Cancer CenterJanssen Services, LLCCompleted
-
Tufts Medical CenterCelgene CorporationCompletedAtopic Dermatitis | Allergic Contact DermatitisUnited States
-
PfizerUCB PharmaCompletedLymphoma, B-CellKorea, Republic of, Canada, Belgium, Singapore, United States, Hong Kong, Japan, United Kingdom, France
-
Omar Nadeem, MDBristol-Myers Squibb; CelgeneRecruitingMultiple Myeloma | Refractory Multiple Myeloma | MyelomaUnited States
-
Canadian Myeloma Research GroupRecruiting
-
M.D. Anderson Cancer CenterRecruitingAcute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
University of ChicagoActive, not recruiting
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Completed
-
AmgenCompletedPsoriatic ArthritisUnited Kingdom, Belgium, United States, Canada, Australia, Taiwan, Czechia, Russian Federation, Hungary, Poland, Korea, Republic of, Italy, New Zealand, France, Bulgaria, Estonia, Romania, Lithuania
-
AmgenCompletedPsoriasis | Psoriatic Arthritis | Psoriasis ArthropaticaJapan
-
Guangxi Medical UniversityGuilin Medical College; Second Affiliated Hospital of Guangzhou Medical University and other collaboratorsUnknownTo Investigate the Characteristics and Prognostic Factors of T. Marneffei Infections and the Causes of Misdiagnosis | To Study the Recurrence Indicators and Establish a Therapeutic Effect Evaluation System of T. Marneffei InfectionsChina
-
CelgeneCompletedMultiple MyelomaSpain, United Kingdom, Switzerland, Australia, Israel, Italy, Poland, France, Belgium, Ireland, Austria, Germany, Ukraine, Greece, Sweden
-
Boston Medical CenterCompletedMultiple MyelomaUnited States
-
National Cancer Institute (NCI)RecruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
AmgenCompletedPsoriasisCanada, Czechia, Germany
-
M.D. Anderson Cancer CenterBristol-Myers SquibbWithdrawnMultiple Myeloma | Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic
-
AllerganCompletedOcular Hypertension | Open-Angle GlaucomaCanada
-
National Cancer Institute (NCI)CompletedCutaneous T-Cell Lymphoma | Peripheral T-Cell Lymphoma | Mature T-cell Malignancies | Relapsed/ Refractory T-cell MalignanciesUnited States
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Myeloproliferative Neoplasm | Acute Myeloid Leukemia With Multilineage Dysplasia | Acute Myeloid Leukemia Post Cytotoxic TherapyUnited States
-
Stanford UniversityRecruitingIschemia | Chest PainUnited States
-
CelgeneCompletedLymphoma, Follicular | Lymphoma, Large B-Cell, DiffuseUnited States
-
AmgenCompletedPsoriatic ArthritisUnited States, United Kingdom, Korea, Republic of, Spain, Germany, Switzerland, Slovakia, Australia, Poland, Russian Federation, Italy, Finland, Canada, Romania, Lithuania, France
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRefractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)Eastern Cooperative Oncology Group; NCIC Clinical Trials Group; SWOG Cancer Research...CompletedStage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic LeukemiaUnited States, Canada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnMantle Cell Lymphoma | CCND1 Positive | CD20-Positive Neoplastic Cells Present
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH); Telix Pharmaceuticals...Active, not recruitingProstate AdenocarcinomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma | Refractory High Grade B-Cell Lymphoma | Recurrent Transformed B-Cell Non-Hodgkin Lymphoma | Refractory Transformed B-Cell Non-Hodgkin LymphomaUnited States
-
M.D. Anderson Cancer CenterNovartisCompleted
-
Case Comprehensive Cancer CenterTerminatedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
CelgeneCompletedMultiple MyelomaAustria
-
AmgenCompleted
-
IRCCS Policlinico S. MatteoCelgene CorporationCompleted
-
Barbara Ann Karmanos Cancer InstituteBristol-Myers Squibb; National Cancer Institute (NCI); Multiple Myeloma Research...Active, not recruitingRecurrent Primary AmyloidosisUnited States
-
Jonsson Comprehensive Cancer CenterNovartis PharmaceuticalsWithdrawnRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | HLA-A*0201 Positive Cells Present | NY-ESO-1 Positive Tumor Cells PresentUnited States
-
CelgeneRecruitingRelapsed or Refractory Multiple MyelomaItaly, Romania, Spain, Germany, Japan, South Africa, United Kingdom, Brazil, France, Greece, Portugal, Austria, Belgium, India, United States, China, Puerto Rico, Israel, New Zealand, Ireland, South Korea, Poland, Chile, Argentina, Aust... and more
-
OncotherapeuticsCelgene CorporationUnknownMultiple MyelomaUnited States
-
King Abdulaziz UniversityCompletedCOVID-19 | Covid19 | SARS-CoV-2 | Coronavirus | Saliva | Viral Load | Polymerase Chain Reaction | MouthwashesSaudi Arabia
-
University of LouisvilleOsteo Science FoundationNot yet recruitingOsteomyelitis of JawUnited States
-
M.D. Anderson Cancer CenterCelgene Corporation; The Leukemia and Lymphoma SocietyCompleted
-
AmgenCompletedPsoriatic ArthritisSpain, Canada, United States, Australia, Hungary, Poland, Austria, France, New Zealand, South Africa, Russian Federation, Germany, United Kingdom
-
Kaohsiung Veterans General Hospital.Completed
-
National Cancer Institute (NCI)RecruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Recurrent Diffuse Large B-Cell Lymphoma, Not... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States